Others

Glenmark Pharmaceuticals Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

| Updated on May 07, 2019 Published on May 07, 2019

Glenmark appoints Dr. Yasir Rawjee as Chief Executive Officer of Glenmark Life Sciences, its subsidiary for the API business

Pdf Link: Glenmark Pharmaceuticals Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Source : BSE - www.bseindia.com

Published on May 07, 2019
This article is closed for comments.
Please Email the Editor